The Hydroxyzine Pamoate Capsules, cataloged under National Stock Number 6505-01-119-0775, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Goldline Laboratories, Inc. Dba Goldline Laboratories. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-119-0775 |
| Primary Part Number | 01-4843 |
| Item Name | Hydroxyzine Pamoate Capsules |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Goldline Laboratories, Inc. Dba Goldline Laboratories |
| Status | ACTIVE |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 1000.000 |
| Active Medicament Medicinal Strength | 25.000 MILLIGRAMS HYDROXYZINE PAMOATE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| 01-4843 PRIMARY | Goldline Laboratories, Inc. Dba Goldline Laboratories (USA) |
| NDC00182-1098-10 PRIMARY | Goldline Laboratories, Inc. Dba Goldline Laboratories (USA) |
| Reference | Meaning |
|---|---|
| NDC00537-6308-10 | 5/9 Secondary reference Spencer-Mead Inc |
NSN 6505-01-119-0775 is a Hydroxyzine Pamoate Capsules, manufactured by Goldline Laboratories, Inc. Dba Goldline Laboratories, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-119-0775 has 2 manufacturer part numbers on file: 01-4843 (Goldline Laboratories, Inc. Dba Goldline Laboratories), NDC00182-1098-10 (Goldline Laboratories, Inc. Dba Goldline Laboratories).
Key specifications for 01-4843: Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Capsule Primary Container Content Quantity: 1000.000; Active Medicament Medicinal Strength: 25.000 MILLIGRAMS HYDROXYZINE PAMOATE ACTIVE INGREDIENT. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.